Epoetin beta
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Epoetin beta (rINN) (Template:PronEng) is a synthetic, recombinant[1] form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
Epoetin is marketed under the trade names NeoRecormon.[2] It is only sold in Europe.
References
References
- ↑ Dunn CJ, Markham A (1996). “Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure”. Drugs. 51 (2): 299–318. PMID 8808169.
- ↑ Amgen – Products. URL: http://www.amgen.com/patients/prca.html. Accessed on: October 21, 2007.
External links
External links
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH